« zurück zum Suchergebnis

Annual report / AstraZeneca

Titel:	Annual report / AstraZeneca : and form 20-F
Körperschaft:	AstraZeneca Plc (Verfasser)
Veröffentlicht:	London, 2000-
Erscheinungsverlauf:	1999(2000) -
Umfang:	Online-Ressource
Format:	Elektronische Zeitschrift
Sprache:	Englisch
Schlagworte:	Zeitschrift
Andere Ausgaben:	Druckausg.: AstraZeneca Plc. Annual report. - London, 2000-

alg: 34009439
001A    $06050:12-05-14 
001B    $01999:03-03-23 $t18:20:05.000 
001D    $06050:10-10-15 
001U    $0utf8 
001X    $00 
002@    $0Obvc 
002C    $aText $btxt $2rdacontent 
002D    $aComputermedien $bc $2rdamedia 
002E    $aOnline-Ressource $bcr $2rdacarrier 
003@    $0340094397 
003O    $01366353381 $aOCoLC 
006Z    $02769856-7 
007A    $02769856-7 $aZDB 
009Q    $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $xH 
010@    $aeng 
011@    $a2000 $n2000- 
013D    $RPresse $RFortlaufendes Sammelwerk $#Periodicals $#Yearbooks $#Périodiques $#Annuaires $#Publicaciones periódicas $#journals $#Periodical $#Periodicals as Topic $#Zeitschrift $#Zeitschrift $#Periodikum $#Zeitschriften $74067488-5 $8Zeitschrift [Tsz] $9085189774 
016A    $aDg 
018@    $0u 
021A    $aAnnual report $dand form 20-F $eAstraZeneca 
029A    $BVerfasser $RAstra AB $RZeneca Group $#Astra Zeneca Plc $#AstraZeneca $4aut $710037826-2 $8AstraZeneca Plc [Tb1] $9104594438 
031@    $a1999(2000) - 
031N    $6 $j1999 
033A    $pLondon 
034D    $aOnline-Ressource 
037A    $aGesehen am 12.05.14 
039D    $aDruckausg. $8--Abvc--AstraZeneca Plc [Tb1]. Annual report. - London, 2000- $9104691409 
045U    $e610 $e630 $e640 

lok: 34009439 3

exp: 34009439 3 1 #EPN
201B/01 $012-05-14 $t22:49:39.328 
201U/01 $0utf8 
203@/01 $0731815734 
208@/01 $a12-05-14 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 5

exp: 34009439 5 1 #EPN
201B/01 $012-05-14 $t22:49:39.336 
201U/01 $0utf8 
203@/01 $0731815742 
208@/01 $a12-05-14 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 8

exp: 34009439 8 1 #EPN
201B/01 $012-05-14 $t22:49:39.340 
201U/01 $0utf8 
203@/01 $0731815750 
208@/01 $a12-05-14 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 10

exp: 34009439 10 1 #EPN
201B/01 $012-05-14 $t22:49:39.344 
201U/01 $0utf8 
203@/01 $0731815769 
208@/01 $a12-05-14 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 11

exp: 34009439 11 1 #EPN
201B/01 $012-05-14 $t22:49:39.347 
201U/01 $0utf8 
203@/01 $0731815777 
208@/01 $a12-05-14 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 20

exp: 34009439 20 1 #EPN
201B/01 $012-05-14 $t22:49:39.350 
201U/01 $0utf8 
203@/01 $0731815785 
208@/01 $a12-05-14 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 21

exp: 34009439 21 1 #EPN
201B/01 $012-05-14 $t22:49:39.353 
201U/01 $0utf8 
203@/01 $0731815793 
208@/01 $a12-05-14 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 23

exp: 34009439 23 1 #EPN
201B/01 $012-05-14 $t22:49:39.356 
201U/01 $0utf8 
203@/01 $0731815807 
208@/01 $a12-05-14 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 24

exp: 34009439 24 1 #EPN
201B/01 $012-05-14 $t22:49:39.359 
201U/01 $0utf8 
203@/01 $0731815815 
208@/01 $a12-05-14 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 25

exp: 34009439 25 1 #EPN
201B/01 $012-05-14 $t22:49:39.362 
201U/01 $0utf8 
203@/01 $0731815823 
208@/01 $a12-05-14 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 107

exp: 34009439 107 1 #EPN
201B/01 $020-03-20 $t16:37:34.531 
201C/01 $020-03-20 
201U/01 $0utf8 
203@/01 $01088634044 
208@/01 $a20-03-20 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 108

exp: 34009439 108 1 #EPN
201B/01 $020-03-20 $t16:37:34.535 
201C/01 $020-03-20 
201U/01 $0utf8 
203@/01 $01088634052 
208@/01 $a20-03-20 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 204

exp: 34009439 204 1 #EPN
201B/01 $012-05-14 $t22:49:39.376 
201U/01 $0utf8 
203@/01 $0731815866 
208@/01 $a12-05-14 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH 

lok: 34009439 205

exp: 34009439 205 1 #EPN
201B/01 $012-05-14 $t22:49:39.378 
201U/01 $0utf8 
203@/01 $0731815874 
208@/01 $a12-05-14 $bl 
209S/01 $S0 $uhttp://www.astrazeneca.com/Investors/Annual-reports $XH

LEADER	00000cas a2200000 c 4500
001	340094397
003	DE-603
005	20230303182005.0
007	cr\|\|\|\|\|\|\|\|\|\|\|\|
008	140512c20009999xx u\| p\|o 0 \|1eng c
016	7		\|2 DE-600 \|a 2769856-7
035			\|a (DE-599)ZDB2769856-7
035			\|a (OCoLC)1366353381
040			\|a DE-603 \|b ger \|c DE-603 \|d DE-603
041			\|a eng
084			\|a 610 \|a 630 \|a 640 \|q DE-600 \|2 sdnb
110	2		\|a AstraZeneca Plc \|e Verfasser \|4 aut \|0 (DE-603)104594438 \|0 (DE-588)10037826-2 \|2 gnd
245	0	0	\|a Annual report / AstraZeneca \|b and form 20-F
264	3	1	\|a London \|c 2000-
300			\|a Online-Ressource
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
362	0		\|a 1999(2000) -
363	0	1	\|8 1.1\x \|i 1999
500			\|a Gesehen am 12.05.14
655		7	\|a Zeitschrift \|2 gnd-content \|0 (DE-588)4067488-5 \|0 (DE-603)085189774
776	0	8	\|i Druckausg. \|a AstraZeneca Plc \|t Annual report \|d London, 2000- \|w (DE-603)104691409 \|w (DE-600)2078629-3
856			\|u http://www.astrazeneca.com/Investors/Annual-reports \|x Verlag \|z kostenfrei
924	1		\|9 603 \|a (DE-603)731815734 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)731815742 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)731815750 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)731815769 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)731815777 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)731815785 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)731815793 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)731815807 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)731815815 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)731815823 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)1088634044 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)1088634052 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)731815866 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)731815874 \|b DE-603 \|c HES \|d d

Annual report / AstraZeneca

Links

Folgen Sie uns auf...